We studied 137 uropathogenic Escherichia coli (UPEC) isolates from hospitalized adult patients (Queensland, Australia) for their resistance to 17 antimicrobial agents using the calibrated dichotomous sensitivity method and the presence of class I, II and III integron-associated integrase (intI) genes, including functional class II intI2, as well as the presence of sul1, sul2 and sul3 genes, using PCR. Randomly amplified polymorphic DNA PCR, a high-resolution biochemical-fingerprinting method (PhP) and phylogenetic grouping were also used to identify the clonality of the sulphonamide-resistant isolates. One hundred and twenty (87.6 %) isolates were resistant to one or more of the tested antimicrobial drugs, with the highest resistance (70.1 %) observed against sulphafurazole (96 isolates). Of these, 84 (87.5 %) contained one or more sul alleles, with sul1 being the most common allele [occurring in 69 (72 %) isolates]. Only 38 of 69 (55.1 %) strains carrying the sul1 gene were positive for class I integrase. Our results indicate a high prevalence of sulphafurazole-resistant UPEC strains belonging to different clones among patients with urinary tract infection in Queensland, Australia. We also conclude that these strains carry predominantly a sul1 gene that is not commonly associated with the presence of class I integrase, indicating that it may be carried on either a bacterial chromosome or other genetic elements.
INTRODUCTION
Urinary tract infection (UTI), although one of the most easily treatable diseases, has been reported to be the most common hospital-acquired infection, affecting mainly women, children and the elderly (Foxman & Brown, 2003; Gupta et al., 2001; Russo & Johnson, 2003; Tartof et al., 2007) . Escherichia coli is the primary aetiological agent, accounting for 75-90 % cases of UTI (Gupta et al., 2001; Kaper et al., 2004; Nicolle, 2002) . The acquisition of resistance genes by horizontal transfer is currently thought to play a major role in the development of multi-drugresistant (MDR) strains because a substantial proportion of the resistance genes are located on conjugative plasmids, transposons, insertion sequences and integrons (Chang et al., 2011; Fierer & Guiney, 1999; Moritz & Hergenrother, 2006) . Integrons are mobile DNA elements with the ability to integrate and express gene cassettes by site-specific recombination (Mazel, 2006; Rowe-Magnus & Mazel, 2002) . Site-specific recombination is catalysed by an integrase that is encoded within the conserved 59 region of integrons. Several classes of integrase have been described with those classes of integrons, i.e. class I integrase (intI1) defines class I integrons (Collis et al., 2002; Nield et al., 2001) .
With the standard treatment for UTI being a combination of trimethoprim and sulphamethoxazole (Grape et al., 2003) , the sulphonamides are classified as a highly important antimicrobial agent for treatment of E. coli infections, and the presence of sulphonamide resistance can lead to treatment failure in cases of UTI. In E. coli, sulphonamide resistance often correlates with the presence of dihydropteroate synthase (DHPS) genes in integrons (Huovinen et al., 1995; Sköld, 2000) . Currently, three different types of DHPS gene (sul1, sul2 and sul3) responsible for sulphonamide resistance have been characterized. The sul1 gene is found exclusively on large conjugative plasmids and on class I integron at the 39 end (Hall & Collis, 1998; Trobos et al., 2009) , whilst sul2 is usually located on plasmids belonging to the IncQ family or another type represented by pB1 (van Treeck et al., 1981) . Although a link between the presence of Table 1 . Distribution of antimicrobial drug-resistance patterns and the presence of integron-associated intI genes among 137 uropathogenic E. coli strains AMC, Amoxicillin-clavulanic acid; AMP, ampicillin; ATM, aztreonam; CAZ, ceftazidime; CEF, cephalothin; CPD, cefpodoxime; CTT, cefotetan; CTX, cefotaxime; FEP, cefepime; GEN 10, gentamicin 10 mg; GEN 200, gentamicin 200 mg; IMI, imipenem; NAL, nalixidic acid; NIT, nitrofurantoin; SF, sulphafurazole; TET, tetracycline; TMP, trimethoprim; TZP, piperacillin-tazobactam.
Resistance
No the sul3 gene and non-classic class I integrons has been proposed (Antunes et al., 2007) , the structure of plasmids carrying sul3 has not been well-described (Wu et al., 2010) . Furthermore, while sul3 has rarely been found, both sul1 and sul2 are highly prevalent (Blahna et al., 2006; Ho et al., 2009; Trobos et al., 2009) .
The aims of this study were to investigate the pattern of antimicrobial resistance, the prevalence of sulphonamideresistant strains and finally the association of sul genes with intI genes among uropathogenic E. coli (UPEC) strains isolated from hospitalized patients with UTI in Queensland, Australia. (Mabbett et al., 2009) . Patients with UTI due to catheterization and those yielding mixed infection were excluded from the study. All isolates were tested for purity on MacConkey agar no. 3 and confirmed as E. coli using the highly specific E. coli universal stress protein (uspA) gene. Chromosomal DNA was extracted by using a Real Biotech Corporation (RBC) Genomic DNA Extraction kit (Blood/Bacterial/Cultured Cells) and an 884 bp fragment of the uspA gene was amplified as described by Chen & Griffiths (1998) . The DNA-amplification reaction mixture (25 ml) contained 17.3 ml MilliQ water, 2.5 ml 106 PCR buffer (Bioline), 1 ml dNTPs (10 mM) (Fisher Biotech), 1.5 ml MgCl 2 (50 mM) (Bioline), 0.25 ml of each uspA primer from a 50 pmol ml 21 stock solution (Invitrogen), 0.2 ml Taq DNA polymerase (Bioline) and 2.0 ml purified DNA template. Amplification was carried out in a thermal cycler and runs included a 5 min initial denaturation step at 95 uC, followed by 30 cycles of 30 s at 94 uC, 30 s at 56 uC and 30 s at 72 uC, and a 5 min final extension step at 72 uC. Amplified PCR products were electrophoresed on 2 % agarose (Amresco) in 0.66 TBE (TrisBase EDTA) buffer, stained with ethidium bromide and viewed under UV light using a Gel Doc system (Bio-Rad). DNA was then stored at 220 uC in elution buffer for further use and the strains were stored on tryptone soya broth with 15 % glycerol at 280 uC for further analysis.
METHODS
Antimicrobial resistance. All isolates were tested for their resistance to 17 commonly used antimicrobial drugs according to the calibrated dichotomous sensitivity (CDS) method (Bell et al., 2006) . The antimicrobials tested were ampicillin (25 mg), amoxicillin-clavulanic acid (60 mg), cefotaxime (5 mg), ceftazidime (10 mg), cefotetan (30 mg), imipenem (10 mg), aztreonam (30 mg), piperacillin-tazobactam (55 mg), cefepime (10 mg), cefpodoxime (10 mg), trimethoprim (5 mg), gentamicin (10 and 200 mg), nalidixic acid (30 mg), cephalothin (30 mg), nitrofurantoin (300 mg), sulphafurazole (300 mg) and tetracycline (30 mg) (a less commonly used drug). All susceptibility tests were calibrated for the chosen antimicrobial drugs using E. coli strain ATCC 25922 for quality control. The CDS method reports antimicrobial drug susceptibilities as either 'susceptible' or 'resistant' and therefore the results were not expressed as MIC values, and instead interpreted only as susceptible or resistant. Isolates with resistance to two or more antimicrobial drugs were regarded as MDR (Bartoloni et al., 2004) .
Phylogenetic grouping. All isolates were tested to determine their phylogenetic groups using PCR according to the method described by Clermont et al. (2000) . The primer pairs used were ChuA-F, 59-GACGAACCAACGGTCAGGAT-39, and ChuA-R, 59-TGCCGCCAG-TACCAAAGACA-39; YjaA-F, 59-TGAAGTGTCAGGAGACGCTG-39, and YjaA-R, 59-ATGGAGAATGCGTTCCTCAAC-39; and TspE4.C2-F, 59-GAGTAATGTCGGGGCATTCA-39, and TspE4.C2-R, 59-CGC-GCCAACAAAGTATTACG-39; these generated fragments of 279, 211 and 152 bp, respectively. Gel electrophoresis was run on 2 % agarose in 0.66 TBE buffer, stained with ethidium bromide and viewed as described above.
Typing of isolates. All sulphonamide-resistant isolates were typed by using the randomly amplified polymorphic DNA (RAPD) PCR method and Phene Plate (PhP) fingerprinting. RAPD-PCR was performed with the PB1 (59-ACACGCACACGGAAGAA-39) primer according to Ramos et al. (2010) . The PCR was carried out in a 50 ml volume containing 5 ml 106 PCR buffer (Bioline), 3.8 ml MgCl 2 (50 mM) (Bioline), 1 ml (10 mM) dNTPs (Fisher Biotech), 5 ml (20 pmol ml 21 ) primer PB1 (Invitrogen), 0.4 ml Taq DNA polymerase (Bioline) and 1.5 ml purified DNA template. PCRs were amplified as described previously (Ramos et al., 2010) and products were sizeseparated by electrophoresis in 2.2 % agarose with ethidium bromide at 90 V for 180 min. Banding patterns were compared visually and divided into similarity groups (RAPD types).
PhP fingerprinting was done by using high-resolution biochemicalfingerprinting PhP-RE plates (PhPlate AB), which were developed specifically to type E. coli strains (Landgren et al., 2005) . Inoculation of the plates was done according to the instructions of the manufacturer and the plates were incubated at 37 uC. The rate of each reaction was evaluated by measuring the A 620 in each well after 7, 24 and 48 h incubation using a digital scanner. After the final scan, PhPlate software v. 4002 (PhPlate AB) was used to create A 620 data from the scanned plate images and the mean A 620 in each well over the three readings was calculated, yielding the biochemical fingerprint for each isolate. The biochemical fingerprints of the isolates were compared pairwise and the similarity between each pair of strains was calculated as the similarity coefficient and clustered by UPGMA (Saeedi et al., 2005; Sneath & Sokal, 1973) . Isolates showing similarity coefficients to each other that were higher than the default identity level of the software (0.975) were regarded as identical and assigned to the same biochemical phenotype. All data handling, including calculations of correlations and coefficients, as well as clustering, was performed using the PhPlate software v. 4002 (PhPlate AB). Strains were regarded as a common clonal group if they had the same RAPD-PCR pattern, PhP type and phylogenetic group; otherwise, they were referred to as a single clone.
Identification of the sul1, sul2 and sul3 genes. All E. coli isolates resistant to sulphafurazole were tested for the presence of the sul1, sul2 and sul3 genes. Multiplex PCR amplification of sul1 and sul2 was performed in a 50 ml volume with 5 ml 106 PCR buffer (Bioline), 2 ml (50 mM) MgCl 2 , 5 ml (2 mM) dNTPs, 0.5 ml (10 pmol ml 21 ) each primer, 2 ml template DNA and 0.5 ml Taq polymerase (Bioline). Conditions of these PCRs were initial denaturation at 94 uC for 5 min, followed by 36 cycles of 94 uC for 15 s, 67 uC for 30 s and 72 uC for 60 s, with a final extension at 72 uC for 7 min. Amplification of the sul1 and sul2 genes was performed with the sul1-F, sul1-R, sul2-F and sul2-R primers described by Kerrn et al. (2002) , which generate fragments of 433 and 293 bp for the sul1 and sul2 genes, respectively. Primers and amplification conditions for the sul3 gene were as described by Hammerum et al. (2006) . The PCR was performed in a 25 ml reaction containing 3 ml 106 PCR buffer, 1 ml 50 mM MgCl 2 , 2.5 ml 2 mM dNTPs, 0.15 ml Taq polymerase (Bioline), 2 ml DNA and 0.5 ml 10 pmol ml 21 primers (sul3-F, 59-GAGCAAGATTTTTGGAATCG-39, and sul3-R, 59-CTAACCTAGGGCTTTGGATAT-39), which generate a 750 bp fragment. Detection of integron-associated intI genes. All E. coli strains were tested for the presence of different classes of integron-associated integrases by using a multiplex PCR as described by Dillon et al. (2005) . The PCR protocol for the intI genes was modified to the following conditions: after initial denaturation at 94 uC for 10 min, the reaction mixture was run through 25 cycles of denaturation at 94 uC for 1 min, annealing at 63 uC for 30 s and extension at 72 uC for 1 min. Cycling was followed by a final extension incubation of 10 min at 72 uC. Negative and positive controls were included in each reaction. Positive controls were E. coli cells containing vectors with inserts possessing integrons of a single class only. All of the positive controls came from a subclone of those described by Long et al. (2009) . These included E. coli uB1637, containing plasmid R388 carrying In3, a class I integron, and E. coli DH5a, containing pMAQ612 carrying Tn7 (class II) or pSMB731 (class III). After amplification, PCR products were separated electrophoretically and viewed as described above. The selected primers for detection of all three classes of integrases were Int1F, 59-CAGTG-GACATAAGCCTGTTC-39, and Int1R, 59-CCCGAGGCATAGACT-GTA-39, for the intI1 gene; Int2F, 59-CACGGATATGCGACAA-AAAGGT-39, and Int2R, 59-GATGACAACGAGTGACGAAATG-39, for the intI2 gene; and Int3F, 59-GCCTCCGGCAGCGACTTTCAG-39, and Int3R, 59-ACGGATCTGCCAAACCTGACT-39, for the intI3 gene, which generate fragments of 160, 788 and 979 bp, respectively.
E. coli strains that harboured class II integrases were tested further for functionality of the protein encoded by the intI2 gene. The primer sets for detection of this gene were HS913, 59-CGCCTAATCCCAGCA-ATAAAAT-39, specific for truncated version of intI2; HS914, 59-GCGCCTAATCCCAGTAATTAAAAC-39, specific for functional version of intI2; and HS502, 59-GTAGCAAACGAGTGACGAAATG-39, as a complementary primer for both. The PCR protocol to detect the Statistical analysis. Differences in the prevalence of intI genes between phylogenetic groups, as well as between antimicrobial drugresistant strains in hospitals, were assessed by using x 2 and Fisher's exact tests. A P-value of ,0.05 was considered statistically significant.
RESULTS
Antimicrobial-resistance patterns of the isolates varied among the hospitals. In all, 119 (88.2 %) isolates were resistant to one or more of the 17 tested antimicrobial drugs, with the highest resistance found against sulphafurazole (70.1 %), ampicillin (50.4 %), cephalothin (50.4 %), trimethoprim (29.6 %) and tetracycline (17.8 %) (Table 1) . Thirteen (9.5 %) isolates were resistant to all of the above five antimicrobial drugs; four patterns, i.e. AMP/SF, AMP/ CEF/SF, AMP/TMP/CEF/SF and AMP/TMP/CEF/TET/SF, found among the strains from all hospitals.
The majority (78.1 %) of the isolates belonged to phylogenetic group B2, whereas 17.5 % belonged to phylogenetic group D. The remaining 4.4 % of isolates belonged to phylogenetic groups A and B1. With the exception of one, all isolates belonging to phylogenetic group D, and 92 of 107 (85.7 %) isolates belonging to phylogenetic group B2 were resistant to at least one of the tested antimicrobial drugs (Table 1) . Strains resistant to trimethoprim, tetracycline, gentamicin and nitrofurantoin were found to be significantly more associated with phylogenetic group D than B2 (Table 2 ).
In all, 54 (39.4 %) isolates were positive for the presence of integrases, with 47 (34.3 %) isolates being positive for class I integron-associated integrase, while seven (5.1 %) isolates were positive for the intI2 gene. Three (2.2 %) isolates carried both class I and II integrases. Class III integrase was Fig. 1 . Association between phylogenetic groups and the presence of integron-associated intI genes among 137 E. coli strains isolated from patients with UTI. Comparison between different phylogenetic groups showed a significant difference between strains in phylogenetic groups B2 (filled bars) and D (empty bars) only. not detected among the isolates. Functionality testing of the protein encoded by the intI2 gene of all seven strains harbouring class II integrases showed that these proteins were non-functional. Comparison of the isolates belonging to different phylogenetic groups showed that strains belonging to group D carried significantly (P,0.001) more intI genes than those belonging to phylogenetic group B2 (Fig. 1 ).
All except two isolates (n552) carrying intI genes were resistant to at least one antimicrobial drug (Table 1 ). The prevalence of MDR isolates among the integrase-positive strains (51 of 54) was significantly (P,0.001) higher than that found among the integrase-negative strains (38 of 83). Furthermore, resistance to trimethoprim, sulphafurazole, ampicillin, cephalothin, tetracycline, gentamicin, nalixidic acid or cefotaxime was significantly more common among isolates harbouring intI genes than among those that did not (Table 3) .
Of the 137 isolates tested, 96 (70 %) were resistant to sulphafurazole. In view of the high prevalence of sulphonamide-resistant strains in our collection, these strains were tested further for three allelic variations of the sul gene (sul1, sul2 and sul3). Table 4 shows the distribution of these allelic genes among both integron-positive and integron-negative strains. Typing of sulphafurazole-resistant isolates showed that the strains belonged to 11 common and 33 single clonal groups. Within each common clonal group, there existed different antimicrobial drug-resistance patterns, intI genes and sul alleles ( Table 5 ). Of these, 84 (87.5 %) carried one or more sul alleles, with sul1 being the most common allele found in 69 (71.8 %) isolates. sul2 and sul3 were found in 64 (66.6 %) and seven (7.2 %) isolates, respectively.
Whilst all integrase-positive isolates carried at least one sul gene, 42 % of isolates carrying sul alleles did not show the presence of any intI genes. Furthermore, 10 isolates carrying class I integrase showed the presence of only the sul2 gene. Statistical analysis also confirmed the lack of a relationship between the presence of class I integrase and the sul1 allele (Table 6) . Similar results were found between the phylogenetic group of the strains and the presence of sul alleles (P50.126). However, strains harbouring the sul2 gene showed a significantly higher prevalence of resistance to ampicillin (P,0.016), trimethoprim (P50.018) and cephalothin (P50.03) (Fig. 2) . Similar results were found with the sul1 gene, except that strains carrying this gene were significantly resistant to only ampicillin (57 % of ampicillinsensitive strains carried the sul1 gene, as opposed to 80 % of ampicillin-resistant strains) (P50.015).
DISCUSSION
Sulphonamides have been used alone or in combination with trimethoprim for treatment of UTIs (Ang et al., 2009; Warren et al., 1999) , which explains the commonly reported high levels of resistance to these antimicrobial agents among E. coli strains (Blahna et al., 2006; Ho et al., 2009) . In our study, we found a high level of resistance to these antimicrobial agents. However, we also found that .61 % of our sulphafurazole-resistant strains were susceptible to trimethoprim, which is markedly different from prevalences reported elsewhere (Bean et al., 2005; Blahna et al., 2006) .
Integron distribution in UPEC has been the subject of several studies (Chang et al., 2007; Farshad et al., 2008; Rao et al., 2006; Rijavec et al., 2006) . These studies have established a strong association between the presence of integrons and antimicrobial resistance, to both multiple and single drugs. E. coli carrying several antibioticresistance genes may act as a donor of those resistance genes to other pathogenic E. coli and even other species. As reported by Leverstein- van Hall et al. (2002 van Hall et al. ( , 2003 , integrons may be a major culprit for the dissemination of antimicrobial resistance, and their prevalence has ranged from 16.6 to 59.0 % in clinical E. coli isolates (Farshad et al., 2008; Márquez et al., 2008b; Mathai et al., 2004; Solberg et al., 2006; Yu et al., 2003) . According to our study, 39.4 % of UTI-causing E. coli possessed class I and II integrases, which is in line with other reports. Our results, however, indicated that the presence of intI genes was associated strongly with the MDR property. We also found that two isolates carrying either intI1 or intI2 genes were susceptible to all antimicrobial drugs tested in our study. It must be noted, however, that the detection of intI genes does not always correlate with the presence of functional integron.
In this study, although the majority of the isolates (78.1 %) belonged to phylogenetic group B2, we found a strong association between the presence of the integron-associated int1 gene and phylogenetic group D, which constituted only 18 % of the isolates. A previous study on E. coli collected from patients with asymptomatic bacteriuria, cystitis and pyelonephritis from one of the three hospitals of this study also indicated a similar distribution of these phylogenetic groups among their isolates (Mabbett et al., 2009) , although the prevalence of virulence genes varied among different pathotypes. In our study, we did not investigate the prevalence of virulence genes among our isolates, as the aims of the study were different.
Class II integrons are normally found in 4-20 % of UPEC strains (Castro et al., 2005) . In these strains, the class II integrase is inactive, due to the presence of a premature inframe stop codon (Hansson et al., 2002) . Barlow & Gobius (2006) reported an E. coli strain in which the stop codon had been replaced by a glutamine codon and suggested that the associated Int2 protein is functional, and concluded that such functional integron genes may represent an additional mechanism by which resistance-gene cassettes could be mobilized in pathogens. Márquez et al. (2008a) developed a set of primers that were able to differentiate functional from non-functional class II integrase. In our study, we used this set of primers to identify the functionality of our strains to mobilize the resistance gene, and we detected the presence of both functional and nonfunctional proteins encoded by our PCR products. Whilst sequencing of these PCR products (309 bp amplicon for functional and 308 bp amplicon for non-functional) did not fully confirm the presence or absence of functional intI and sul genes in uropathogenic E. coli intI2 genes, full sequencing of the 788 bp intI2 amplicon indicated that these strains in fact did not carry a functional class II integrase. We therefore recommend that, to avoid any false-positive results, all strains showing positive results for functional class II integrase using primer sets HS914/HS502 should be tested by sequencing the 788 bp intI2 amplicon.
Although the pattern of gene-frequency distribution in most published data is sul2.sul1.sul3 (Blahna et al., 2006; Grape et al., 2003; Infante et al., 2005; Kerrn et al., 2002) , our results indicated that this pattern for UPEC isolates in Queensland, Australia, was sul1.sul2.sul3. The relationship between integron class I and the sulphonamide-resistance gene (sul1) as a conserved segment of an integron class I component has frequently been pointed out before (Ho et al., 2009; Kerrn et al., 2002; Sköld, 2000) . However, in our study we found that 45 % of isolates carrying the sul1 allele did not show a positive PCR result for the presence of class I integrase; also, 10 strains of 96 carrying intI1 were not positive for the presence of the sul1 gene, which is of interest because these strains were sul2-positive. The sul1 gene is a conserved region for class I integron, although it has been referred to as a semiconserved segment . In our study, we found that majority of strains carrying the sul1 gene belonged to diverse clonal groups. Interestingly, these strains did not carry class I integrase. In contrast to that, we found that 10 sulphafurazole-resistant strains carrying the integron-associated intI1 gene did not carry the sul1 gene. These findings suggest either that class I integrons in our isolates have lost the sul1 gene region or that this gene is carried on another genetic context in these strains. Similar findings have been reported by others Infante et al., 2005; Kerrn et al., 2002) . Furthermore, we also found that about 13 % of isolates that were resistant to sulphafurazole did not harbour any sul alleles. This might be because of the limitations of our disc-diffusion method or the presence of other sul alleles in those strains responsible for sulphonamide resistance. Nonetheless, this figure is much higher than those reported elsewhere (Frank et al., 2007; Grape et al., 2005; Kerrn et al., 2002) .
The loss and gain of mobile genetic elements is an important mechanism that disseminates new traits rapidly to recipient micro-organisms. For instance, acquisition of resistance genes by horizontal transfer is the main role in the development of MDR strains (Chang et al., 2011; Moritz & Hergenrother, 2006) . Naturally, the recipient microorganism would be able to colonize a new environment when selective pressures select for variants that can survive these pressures (Croxen & Finlay, 2010) . From an evolutionary point of view, the emergence of a new pathotype of E. coli could be due to multiple horizontal gene transfer that exposes these bacteria to new selective pressures. Such selective pressures may eventually select for more virulent organisms that disseminate to become an epidemic clone, such as those seen with enterohaemorrhagic and enteroinvasive E. coli (Wirth et al., 2006) . In our study, the high diversity found among sulphafurazole-resistant strains indicated that the majority of strains carrying the sul gene were not members of the same clone and the high prevalence of these strains among patients with UTI is not due to the dissemination of a single or a few clones of UPEC in these three hospitals. The presence of different antimicrobial drug-resistance patterns and phylogenetic groups among these isolates further supports this conclusion.
